Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Pharma Firm Launches Online 'Addiction411'
August 13, 2007

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

Pharmaceutical firm Reckitt Benckiser -- which makes the anti-addiction medication Suboxone -- has launched a new MySpace health-information site focused on addiction to opioid-based painkillers, called Addiction411.

The company said the website will include information on the dangers associated with opioid abuse, warning signs of addiction, an interactive addiction questionnaire, information on treatment options, a treatment locator, and other resources.

"We are proud to be the first pharmaceutical company to partner with MySpace to provide their members with vital healthcare information," said Reckitt president Shaun Thaxter. "Dependence on opioid painkillers and heroin is a major public-health crisis, and the rise of MySpace as a leading online community makes it an ideal way to share important information about this hidden epidemic. Our hope is that providing the MySpace generation information on opioid dependence will help prevent them from becoming dependent, or will allow them to find appropriate medical help for themselves, their friends, or their families."

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.